SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-089656
Filing Date
2022-08-12
Accepted
2022-08-12 06:51:02
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lptx-20220630x10q.htm   iXBRL 10-Q 1363094
2 EXHIBIT 10.1 lptx-20220630xex10d1.htm EX-10.1 21439
3 EXHIBIT-31.1 lptx-20220630xex31d1.htm EX-31.1 11784
4 EXHIBIT-32.1 lptx-20220630xex32d1.htm EX-32.1 9355
  Complete submission text file 0001104659-22-089656.txt   5455868

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220630.xsd EX-101.SCH 34925
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lptx-20220630_cal.xml EX-101.CAL 36967
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lptx-20220630_def.xml EX-101.DEF 133362
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220630_lab.xml EX-101.LAB 362470
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220630_pre.xml EX-101.PRE 252132
50 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20220630x10q_htm.xml XML 921170
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 221157761
SIC: 2834 Pharmaceutical Preparations